CYH

SEC source: 0001193125-26-365379 · ownership.xml · nonDerivative · entry 1

JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,468

F1 · price: The price reported in Column 4 is a weighted average price of $2.959 per share. These shares were sold in multiple transactions on 08/25/2026 at prices ranging from $2.945 to $2.975, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-290763 · ownership.xml · derivative · entry 2

Krishnan K Ranga · CIK 0001724829 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,722.712

Underlying: Common Stock · 13,930.678 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Pursuant to the Company's Directors' Fees Deferral Plan, a cash payment was made to the Reporting Person in lieu of the fractional stock units (0.678), which are cancelled and do not convert into fractional shares of the Issuer's common stock.

F1 · derivative.exercise_date: These stock units were accrued under the Issuer's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's director cash compensation and are settled in shares of the Issuer's common stock on a one-for-one basis on the last business day of the calendar quarter following Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

F1 · derivative.expiration_date: These stock units were accrued under the Issuer's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's director cash compensation and are settled in shares of the Issuer's common stock on a one-for-one basis on the last business day of the calendar quarter following Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

SEC source: 0001193125-26-290763 · ownership.xml · nonDerivative · entry 1

Krishnan K Ranga · CIK 0001724829 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,023

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock units were accrued under the Issuer's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's director cash compensation and are settled in shares of the Issuer's common stock on a one-for-one basis on the last business day of the calendar quarter following Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

SEC source: 0001193125-26-251834 · ownership.xml · derivative · entry 3

Rice David V. · CIK 0002135141 · EVP-Clinical Operations & CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-05-31

F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-251834 · ownership.xml · derivative · entry 2

Rice David V. · CIK 0002135141 · EVP-Clinical Operations & CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on 3/1/2029, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on 3/1/2029, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

SEC source: 0001193125-26-251834 · ownership.xml · nonDerivative · entry 1

Rice David V. · CIK 0002135141 · EVP-Clinical Operations & CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-170659 · ownership.xml · derivative · entry 2

Krishnan K Ranga · CIK 0001724829 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,321

Underlying: Common Stock · 46,950 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units originally granted on 3/1/2022 and 3/1/2023 settled in shares of the Issuer's common stock on a one-for-one basis on 4/22/2026, the date previously specified by the Reporting Person.

F2 · derivative.exercise_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

F2 · derivative.expiration_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

SEC source: 0001193125-26-170659 · ownership.xml · nonDerivative · entry 1

Krishnan K Ranga · CIK 0001724829 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,093

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units originally granted on 3/1/2022 and 3/1/2023 settled in shares of the Issuer's common stock on a one-for-one basis on 4/22/2026, the date previously specified by the Reporting Person.

SEC source: 0001193125-26-088482 · ownership.xml · nonDerivative · entry 1

SMITH WAYNE T · CIK 0001018660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,217,579

F1 · shares: These shares were gifted to individuals who do not share the Reporting Person's household.

SEC source: 0001193125-26-088520 · ownership.xml · derivative · entry 6

STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-02-29

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-088520 · ownership.xml · derivative · entry 5

STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

SEC source: 0001193125-26-088520 · ownership.xml · derivative · entry 4

STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.

SEC source: 0001193125-26-088520 · ownership.xml · nonDerivative · entry 3

STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 208,290

SEC source: 0001193125-26-088520 · ownership.xml · nonDerivative · entry 2

STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,863

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-088520 · ownership.xml · nonDerivative · entry 1

STOCKTON KEVIN A · CIK 0001862464 · EVP, Operations & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.

SEC source: 0001193125-26-088512 · ownership.xml · derivative · entry 4

Posey Phillip A. · CIK 0002103555 · SVP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-02-29

F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-088512 · ownership.xml · derivative · entry 3

Posey Phillip A. · CIK 0002103555 · SVP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires not disclosed

F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

SEC source: 0001193125-26-088512 · ownership.xml · nonDerivative · entry 2

Posey Phillip A. · CIK 0002103555 · SVP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,736

SEC source: 0001193125-26-088512 · ownership.xml · nonDerivative · entry 1

Posey Phillip A. · CIK 0002103555 · SVP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,924

F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-088501 · ownership.xml · derivative · entry 6

Johnson Jason K · CIK 0001798438 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2036-02-29

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-088501 · ownership.xml · derivative · entry 5

Johnson Jason K · CIK 0001798438 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 180,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 40% to a Cumulative Same-Store Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 40% to a Cumulative Same-Store Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

SEC source: 0001193125-26-088501 · ownership.xml · derivative · entry 4

Johnson Jason K · CIK 0001798438 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.

SEC source: 0001193125-26-088501 · ownership.xml · nonDerivative · entry 3

Johnson Jason K · CIK 0001798438 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 268,439

SEC source: 0001193125-26-088501 · ownership.xml · nonDerivative · entry 2

Johnson Jason K · CIK 0001798438 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 292,049

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-088501 · ownership.xml · nonDerivative · entry 1

Johnson Jason K · CIK 0001798438 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.

SEC source: 0001193125-26-088507 · ownership.xml · derivative · entry 6

Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2036-02-29

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-088507 · ownership.xml · derivative · entry 5

Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

SEC source: 0001193125-26-088507 · ownership.xml · derivative · entry 4

Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.

SEC source: 0001193125-26-088507 · ownership.xml · nonDerivative · entry 3

Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,750

SEC source: 0001193125-26-088507 · ownership.xml · nonDerivative · entry 2

Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 312,672

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-088507 · ownership.xml · nonDerivative · entry 1

Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,672

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.

SEC source: 0001193125-26-088495 · ownership.xml · derivative · entry 7

HAMMONS KEVIN J · CIK 0001542264 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2036-02-29

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-088495 · ownership.xml · derivative · entry 6

HAMMONS KEVIN J · CIK 0001542264 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 40% to a Cumulative Same-Store Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 40% to a Cumulative Same-Store Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.

SEC source: 0001193125-26-088495 · ownership.xml · derivative · entry 5

HAMMONS KEVIN J · CIK 0001542264 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,760 shares

Expires not disclosed

F1 · derivative.exercise_date: The vesting of these 180,000 performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 86.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023 (156,240), and the remaining 13.2% of the target number has been forfeited (23,760).

F1 · derivative.expiration_date: The vesting of these 180,000 performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 86.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023 (156,240), and the remaining 13.2% of the target number has been forfeited (23,760).

SEC source: 0001193125-26-088495 · ownership.xml · derivative · entry 4

HAMMONS KEVIN J · CIK 0001542264 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,760

Underlying: Common Stock · 156,240 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these 180,000 performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 86.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023 (156,240), and the remaining 13.2% of the target number has been forfeited (23,760).

F1 · derivative.expiration_date: The vesting of these 180,000 performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 86.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023 (156,240), and the remaining 13.2% of the target number has been forfeited (23,760).

SEC source: 0001193125-26-088495 · ownership.xml · nonDerivative · entry 3

HAMMONS KEVIN J · CIK 0001542264 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 895,545

SEC source: 0001193125-26-088495 · ownership.xml · nonDerivative · entry 2

HAMMONS KEVIN J · CIK 0001542264 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 992,441

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

SEC source: 0001193125-26-088495 · ownership.xml · nonDerivative · entry 1

HAMMONS KEVIN J · CIK 0001542264 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 792,441

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these 180,000 performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 86.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023 (156,240), and the remaining 13.2% of the target number has been forfeited (23,760).

SEC source: 0001193125-26-088486 · ownership.xml · derivative · entry 7

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,023

Underlying: Common Stock · 52,023 shares

Expires not disclosed

F2 · derivative.exercise_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

F2 · derivative.expiration_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

SEC source: 0001193125-26-088486 · ownership.xml · derivative · entry 6

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,868

Underlying: Common Stock · 19,933 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

F2 · derivative.expiration_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

SEC source: 0001193125-26-088486 · ownership.xml · derivative · entry 5

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,906

Underlying: Common Stock · 20,906 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

F2 · derivative.expiration_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

SEC source: 0001193125-26-088486 · ownership.xml · derivative · entry 4

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,756 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

F2 · derivative.expiration_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

SEC source: 0001193125-26-088486 · ownership.xml · nonDerivative · entry 3

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The security converts to common stock on a one-to-one basis.

SEC source: 0001193125-26-088486 · ownership.xml · nonDerivative · entry 2

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,930

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The security converts to common stock on a one-to-one basis.

SEC source: 0001193125-26-088486 · ownership.xml · nonDerivative · entry 1

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,024

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The security converts to common stock on a one-to-one basis.

SEC source: 0001193125-26-088482 · ownership.xml · derivative · entry 4

SMITH WAYNE T · CIK 0001018660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 339,233

Underlying: Common Stock · 52,023 shares

Expires not disclosed

F2 · derivative.exercise_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

F2 · derivative.expiration_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

SEC source: 0001193125-26-088459 · ownership.xml · derivative · entry 2

Krishnan K Ranga · CIK 0001724829 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,271

Underlying: Common Stock · 52,023 shares

Expires not disclosed

F1 · derivative.exercise_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

F1 · derivative.expiration_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

SEC source: 0001193125-26-088472 · ownership.xml · derivative · entry 2

LOPEZ FAWN D · CIK 0002021315 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,023

Underlying: Common Stock · 52,023 shares

Expires not disclosed

F1 · derivative.exercise_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

F1 · derivative.expiration_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

SEC source: 0001193125-26-088454 · ownership.xml · derivative · entry 2

JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,271

Underlying: Common Stock · 52,023 shares

Expires not disclosed

F1 · derivative.exercise_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

F1 · derivative.expiration_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

SEC source: 0001193125-26-088443 · ownership.xml · derivative · entry 7

Hirsch Elizabeth T · CIK 0001508503 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,023

Underlying: Common Stock · 52,023 shares

Expires not disclosed

F2 · derivative.exercise_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

F2 · derivative.expiration_date: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.